Literature DB >> 3266233

Neurotoxic damage to the nigrostriatal system in rats following intranigral administration of MPDP+ and MPP+.

C J Sun1, J N Johannessen, W Gessner, I Namura, W Singhaniyom, A Brossi, C C Chiueh.   

Abstract

Unilateral intranigral administration of the oxidative metabolites of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), 1-methyl-4-phenyl-dihydropyridine (MPDP+) or 1-methyl-4-phenylpyridine (MPP+) produced dose-dependently a depletion of dopamine in the ipsilateral striatum of rats two weeks following treatment. d-Amphetamine and apomorphine induced circling toward the lesioned side in these unilaterally treated animals. No contralateral circling behavior was observed after challenging with apomorphine. This dopamine lesioning effect of MPP+ was not blocked by pretreatment of animals with a dopamine uptake blocker, GBR 12909. Furthermore, MPP+ increased the 45Ca accumulation into cells at the site of injection and produced "nonspecific" cell membrane and/or cytotoxic damage seen by histological procedures. These results indicate that MPDP+ and MPP+ produced localized cytotoxic damage to nigrostriatal neurons, caused a decrease in striatal dopamine, and disrupted the nigrostriatal system's functioning following intranigral administration to rats. It is postulated that the cationic surfactant properties of MPDP+ and MPP+ might contribute to its neurotoxic effects.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3266233     DOI: 10.1007/bf01245141

Source DB:  PubMed          Journal:  J Neural Transm            Impact factor:   3.575


  30 in total

1.  Dopamine in the extrapyramidal motor function. A study based upon the MPTP-induced primate model of parkinsonism.

Authors:  C C Chiueh
Journal:  Ann N Y Acad Sci       Date:  1988       Impact factor: 5.691

2.  Differences in the metabolism of MPTP in the rodent and primate parallel differences in sensitivity to its neurotoxic effects.

Authors:  J N Johannessen; C C Chiueh; R S Burns; S P Markey
Journal:  Life Sci       Date:  1985-01-21       Impact factor: 5.037

Review 3.  The role of calcium in cell death.

Authors:  J L Farber
Journal:  Life Sci       Date:  1981-09-28       Impact factor: 5.037

4.  The clinical syndrome of striatal dopamine deficiency. Parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).

Authors:  R S Burns; P A LeWitt; M H Ebert; H Pakkenberg; I J Kopin
Journal:  N Engl J Med       Date:  1985-05-30       Impact factor: 91.245

5.  Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidase.

Authors:  K Chiba; A Trevor; N Castagnoli
Journal:  Biochem Biophys Res Commun       Date:  1984-04-30       Impact factor: 3.575

6.  Inhibition of dopamine uptake by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, a cause of parkinsonism.

Authors:  T Denton; B D Howard
Journal:  Biochem Biophys Res Commun       Date:  1984-03-30       Impact factor: 3.575

7.  Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6 -tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity.

Authors:  J A Javitch; R J D'Amato; S M Strittmatter; S H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  1985-04       Impact factor: 11.205

8.  Calcium dependence of toxic cell death: a final common pathway.

Authors:  F A Schanne; A B Kane; E E Young; J L Farber
Journal:  Science       Date:  1979-11-09       Impact factor: 47.728

9.  1-methyl-4-phenylpyridine is neurotoxic to the nigrostriatal dopamine pathway.

Authors:  A J Bradbury; B Costall; A M Domeney; P Jenner; M E Kelly; C D Marsden; R J Naylor
Journal:  Nature       Date:  1986 Jan 2-8       Impact factor: 49.962

10.  Intraneuronal generation of a pyridinium metabolite may cause drug-induced parkinsonism.

Authors:  S P Markey; J N Johannessen; C C Chiueh; R S Burns; M A Herkenham
Journal:  Nature       Date:  1984 Oct 4-10       Impact factor: 49.962

View more
  7 in total

1.  Neuronal protective and rescue effects of deprenyl against MPP+ dopaminergic toxicity.

Authors:  R M Wu; D L Murphy; C C Chiueh
Journal:  J Neural Transm Gen Sect       Date:  1995

2.  MPTP-induced deficits in motor activity: neuroprotective effects of the spintrapping agent, alpha-phenyl-tert-butyl-nitrone (PBN).

Authors:  A Fredriksson; P Eriksson; T Archer
Journal:  J Neural Transm (Vienna)       Date:  1997       Impact factor: 3.575

3.  Evidence for hydroxyl radical scavenging action of nitric oxide donors in the protection against 1-methyl-4-phenylpyridinium-induced neurotoxicity in rats.

Authors:  Rebecca Banerjee; Karuppagounder S Saravanan; Bobby Thomas; Kizhake M Sindhu; Kochupurackal P Mohanakumar
Journal:  Neurochem Res       Date:  2007-09-01       Impact factor: 3.996

4.  In vivo trapping of hydroxyl free radicals in the striatum utilizing intracranial microdialysis perfusion of salicylate: effects of MPTP, MPDP+, and MPP+.

Authors:  T Obata; C C Chiueh
Journal:  J Neural Transm Gen Sect       Date:  1992

5.  Mapping of the colocalization of calretinin and tyrosine hydroxylase in the rat substantia nigra and ventral tegmental area.

Authors:  K R Isaacs; D M Jacobowitz
Journal:  Exp Brain Res       Date:  1994       Impact factor: 1.972

Review 6.  Nitric oxide and MPP+-induced hydroxyl radical generation.

Authors:  T Obata
Journal:  J Neural Transm (Vienna)       Date:  2006-02-06       Impact factor: 3.575

7.  Direct intranigral injection of dopaminochrome causes degeneration of dopamine neurons.

Authors:  Jillienne C Touchette; Julie M Breckenridge; Gerald H Wilken; Heather Macarthur
Journal:  Neurosci Lett       Date:  2015-12-15       Impact factor: 3.046

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.